Cargando…
Reply to “Follistatin-like protein 1 and chronic liver disease progression: a novel pro-inflammatory and pro-fibrogenic mediator?”
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906201/ https://www.ncbi.nlm.nih.gov/pubmed/36760258 http://dx.doi.org/10.21037/atm-2022-74 |
| _version_ | 1784883954878251008 |
|---|---|
| author | Rao, Jianhua Wang, Hao Ni, Ming Liu, Mu Lu, Ling |
| author_facet | Rao, Jianhua Wang, Hao Ni, Ming Liu, Mu Lu, Ling |
| author_sort | Rao, Jianhua |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9906201 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99062012023-02-08 Reply to “Follistatin-like protein 1 and chronic liver disease progression: a novel pro-inflammatory and pro-fibrogenic mediator?” Rao, Jianhua Wang, Hao Ni, Ming Liu, Mu Lu, Ling Ann Transl Med Letter to the Editor AME Publishing Company 2022-12-16 2023-01-15 /pmc/articles/PMC9906201/ /pubmed/36760258 http://dx.doi.org/10.21037/atm-2022-74 Text en 2023 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Letter to the Editor Rao, Jianhua Wang, Hao Ni, Ming Liu, Mu Lu, Ling Reply to “Follistatin-like protein 1 and chronic liver disease progression: a novel pro-inflammatory and pro-fibrogenic mediator?” |
| title | Reply to “Follistatin-like protein 1 and chronic liver disease progression: a novel pro-inflammatory and pro-fibrogenic mediator?” |
| title_full | Reply to “Follistatin-like protein 1 and chronic liver disease progression: a novel pro-inflammatory and pro-fibrogenic mediator?” |
| title_fullStr | Reply to “Follistatin-like protein 1 and chronic liver disease progression: a novel pro-inflammatory and pro-fibrogenic mediator?” |
| title_full_unstemmed | Reply to “Follistatin-like protein 1 and chronic liver disease progression: a novel pro-inflammatory and pro-fibrogenic mediator?” |
| title_short | Reply to “Follistatin-like protein 1 and chronic liver disease progression: a novel pro-inflammatory and pro-fibrogenic mediator?” |
| title_sort | reply to “follistatin-like protein 1 and chronic liver disease progression: a novel pro-inflammatory and pro-fibrogenic mediator?” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906201/ https://www.ncbi.nlm.nih.gov/pubmed/36760258 http://dx.doi.org/10.21037/atm-2022-74 |
| work_keys_str_mv | AT raojianhua replytofollistatinlikeprotein1andchronicliverdiseaseprogressionanovelproinflammatoryandprofibrogenicmediator AT wanghao replytofollistatinlikeprotein1andchronicliverdiseaseprogressionanovelproinflammatoryandprofibrogenicmediator AT niming replytofollistatinlikeprotein1andchronicliverdiseaseprogressionanovelproinflammatoryandprofibrogenicmediator AT liumu replytofollistatinlikeprotein1andchronicliverdiseaseprogressionanovelproinflammatoryandprofibrogenicmediator AT luling replytofollistatinlikeprotein1andchronicliverdiseaseprogressionanovelproinflammatoryandprofibrogenicmediator |